Advertisement

Topics

Vitamin Shoppe, Inc. Announces Second Quarter 2017 Results

02:09 EDT 9 Aug 2017 | PR Newswire

SECAUCUS, N.J., Aug. 9, 2017 /PRNewswire/ --

Second Quarter 2017 Highlights:

  • Total Comparable Sales Down 8.3%
    • Sports-related categories primary drivers of decline
  • GAAP loss per share of $6.73
    • Records impairment charges of $168.1 million
  • Company Launches Sales Driving Initiatives to Improve Competitiveness
    • New pricing strategy
    • SPARK™ Auto-Delivery subscriptions
  • Supply Chain and Manufacturing Restructuring to Further Reduce Costs
    • Rationalization of supply chain network – to close New Jersey distribution center in addition to continued restructuring at Nutri-Force

Vitamin Shoppe, Inc. (NYSE: VSI), an omni-channel, specialty retailer and manufacturer of nutritional products, today announced preliminary results for the three months ended July 1, 2017.  Total net sales in the second quarter were $304.8 million compared to $332.7 million in the same period of the prior year.  Reported basic and fully diluted loss per share in second quarter 2017 was $6.73, compared to fully diluted earnings per share of $0.44 in second quarter 2016.  Results in second quarter 2017 include the following pre-tax expenses; $168.1 million for impairments and $13.7 million charge associated with the Nutri-Force turnaround, while second quarter 2016 results include approximately $3.4 million of costs related to strategic initiatives.  Excluding these items in both periods, adjusted EPS was $0.23 and $0.55, in second quarter 2017 and second quarter 2016, respectively.  Second quarter 2017 was also negatively impacted by $1.2 million from discrete tax charges related to changes in accounting for stock compensation and other permanent tax differences.  (Refer to Table 4 at the end of this press release.) 

Commenting on the quarter's results, Colin Watts, Chief Executive Officer of the Vitamin Shoppe stated, "The results during the quarter were disappointing and the challenges are clear.  The market environment evolved more quickly than we anticipated particularly in the Sports categories.  We have taken decisive actions to improve our performance directly focused on customer acquisition, price/value and customer retention with programs rolled out across the chain.  Additionally, we continue to make progress on our reinvention initiatives and further cost restructuring programs that will help improve results well into 2018."

Second Quarter 2017 Results 
Total sales of $304.8 million in the quarter were 8.4% lower than the same period of the prior year.  Total comparable sales were down 8.3% in the quarter reflecting a 7.6% decline in retail store comparable sales and a 20.2% decrease in vitaminshoppe.com comparable sales.  The decrease in comparable sales was partially impacted by a sales promotion last year that was not repeated, as well as ongoing challenges with the sports customer.  The Company opened three stores in the quarter, and transformed seven into the new brand defining store [BDS] format.  Manufacturing sales to Vitamin Shoppe increased 63.6%, while third party sales decreased 27.8% from the same period of the prior year as the Company continues to right-size this business.

Cost of goods sold, which includes product, distribution, manufacturing and store occupancy costs, decreased $6.7 million, or 3.0%, to $218.2 million for the three months ended July 1, 2017, compared with $224.9 million for the three months ended June 25, 2016.  During the quarter, the Company reported a $10.7 million restructuring expense for Nutri-Force related to inventory obsolescence and equipment impairment charges.

Gross profit of $86.6 million was 19.7% lower than $107.8 million in second quarter 2016.  Reported gross profit as a percentage of net sales was 28.4% in second quarter 2017, compared to 32.4% in the same period of 2016.  Excluding the inventory charge mentioned above, gross profit was $97.3 million in the quarter and the adjusted gross profit as a percentage of sales was 31.9%.  The second quarter 2017 year over year decrease was primarily due to deleverage in occupancy and supply chain from lower sales.  This was partially offset by improvements in margin from favorable category and private brands mix shifts and lower costs through new vendor partnerships.

Reported selling, general and administrative expenses (SG&A), including operating payroll and related benefits and advertising expense, was $86.8 million for the quarter ended July 1, 2017, compared with $87.1 million for the quarter ended June 25, 2016.  SG&A in second quarter 2017 included $3.0 million in turnaround expenses for Nutri-Force.  SG&A in second quarter 2016 included $3.4 million related to strategic initiatives.  Excluding these items for both periods, SG&A as a percent of revenue was 27.5% in second quarter 2017 and 25.2% in second quarter 2016. (For further information on adjustments see Table 4 at the end of this release.)  The increase in the SG&A rate in second quarter 2017 was primarily driven by deleverage due to lower sales.

During the second quarter, impairment indicators were identified, including a significant decline in both the quarter's performance and the Company's market capitalization.  An interim test on the valuation of intangible assets was performed, including revised expectations on future performance which resulted in a goodwill impairment charge of $164.3 million for the retail reporting unit.  In addition, a $3.8 million impairment charge for the fixed asset balances for 24 retail store locations was recorded.

Reported operating loss in second quarter 2017 of $168.3 million compared to operating income of $20.7 million in the same period of the prior year.  Adjusted for the items noted in the preceding paragraphs, income from operations as a percentage of sales was 4.4% in second quarter 2017 and 7.2% in second quarter 2016.  (See Table 4.)

The overall effective income tax rate for the quarter was impacted by partial non-deductibility of the goodwill impairment charge and other permanent tax differences.  Of the $164.3 million goodwill impairment charge, $130.9 million was not deductible for tax purposes.  Additionally, during the second quarter, $1.2 million of discrete tax charges were recorded in income tax expense.  These adjustments relate primarily to the effect of the new accounting guidance. The Company adopted in fiscal 2017, ASU 2016-09, Compensation-Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting, requiring excess tax benefits and deficiencies from stock-based compensation to be recorded in tax expense in the period in which they occur.

Reported net loss was $156.4 million for second quarter 2017 compared to net income of $10.4 million in the same period of the prior year.  Reported loss per share was $6.73 in second quarter 2017, compared to earnings per share of $0.44 in second quarter 2016.  Earnings per share, on an adjusted basis (for the items described in Table 4), was $0.23 and $0.55 for the second quarters of 2017 and 2016, respectively.

Balance Sheet and Cash Flow 
Cash and equivalents at July 1, 2017 were $2.0 million.  At quarter end, the Company had $3.0 million borrowed on its revolving line of credit and a convertible notes liability of $123.6 million.

Capital expenditures were $18.2 million in the quarter.  Funds were primarily expended on the new distribution center, new and remodeled stores, supply chain, digital and other IT investments.

Additional Information
The Company plans to close the North Bergen, New Jersey distribution center prior to, or by, the August 31, 2018 lease expiration.  Distribution operations will be transitioned to the Company's other distribution centers and will be substantially completed by the end of fiscal year 2017.  Costs related to this closure such as severance, inventory-related costs and other charges are estimated to be approximately $4.0 million.  As a result of this closure the Company anticipates annualized savings between $4.0 million to $5.0 million upon lease expiration.

2017 Outlook Given the unprecedented level of volatility in the market and the potential increase in variability of the Company's results due to the number of initiatives being launched in the back half of the year, the Company has reset its 2017 outlook and is modifying its approach to guidance.  The Company is providing guidance around the key levers that drive the business instead of providing specific EPS guidance.

  • The Company expects full year comparable sales decline rate of negative mid-single digits.
  • Reported full year gross margin rate of 30.2% to 30.7%.  This includes charges associated with the Nutri-Force restructuring and North Bergen closure this year.  Excluding these charges, full year gross margins of 31.3% to 31.8% (Refer to Table 5 at the end of this press release.).
  • Full year SG&A expense of $342 million to $347 million including charges associated with the Nutri-Force restructuring.  Excluding these charges, full year SG&A expense of $335 million to $340 million (Refer to Table 5 at the end of this press release.).
  • Full year capital expenditures of $45 million, including build out of distribution center in Arizona, IT investments, approximately 15 new stores and 10-15 brand defining store transformations.

Non-GAAP Financial Measures 
Adjusted information is non-GAAP financial information. These supplemental non-GAAP measures should not be considered superior to, or a substitute for, and should be considered in conjunction with the GAAP financial measures presented.  The Company believes such non-GAAP financial information facilitates analysis and comparisons of our ongoing business operations because it excludes items that may not be indicative of, or are unrelated to the Company's and our business segments' core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying businesses. These adjustments are consistent with how management views our businesses. Management uses such non-GAAP financial information in making financial, operating and planning decisions and evaluating the Company's and each business segment's ongoing performance. A reconciliation of adjusted financial information to the most directly comparable financial measures calculated and presented in accordance with GAAP is shown in Tables 4 and 5.

WebcastManagement will host a conference call to discuss the second quarter 2017 results at 8:30 a.m. Eastern Time (ET) today.  Interested investors and other parties may listen to the simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.vitaminshoppe.com.  A telephonic replay will be available beginning at 11:30 a.m. ET on August 9, 2017 and can be accessed by dialing 1-844-512-2921 or 1-412-317-6671 for international callers. The passcode for the replay is 2717553.  The telephonic replay will be available until 11:59 p.m. ET on August 16, 2017.The webcast will also be archived on the company's website at www.vitaminshoppe.com in the investor relations section.

About the Vitamin Shoppe, Inc. (NYSE:VSI)  
Vitamin Shoppe is an omni-channel, specialty retailer and contract manufacturer of nutritional products based in Secaucus, New Jersey.  In its stores and on its website, the Company carries a comprehensive retail assortment including: vitamins, minerals, specialty supplements, herbs, sports nutrition, homeopathic remedies, green living products, and beauty aids.  In addition to offering products from approximately 900 national brands, the Vitamin Shoppe also carries products under The Vitamin Shoppe®, BodyTech®, True Athlete®, MyTrition®, plnt®, ProBioCare®, Next Step® and Betancourt Nutrition® brands.  The Vitamin Shoppe conducts business through more than 775 company-operated retail stores under The Vitamin Shoppe and Super Supplements retail banners, and through its website, www.vitaminshoppe.com.  Follow the Vitamin Shoppe on Facebook at http://www.facebook.com/THEVITAMINSHOPPE and on Twitter at http://twitter.com/VitaminShoppe.

Forward Looking Statements 
This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including without limitation, statements under the caption "2017 Outlook", statements regarding future financial results and performance, share repurchases, future business prospects, revenue, new stores, product offerings, store growth, working capital, liquidity, capital expenditures, capital needs and interest costs, industry based factors, including the level of competition in the vitamin, mineral and supplement industry, continued demand from the primary markets the Company serves, consumer perception of the Company's products, the availability of raw materials as well as economic conditions generally and factors more specific to the Company such as compliance with manufacturing regulations, certifications and practices and restrictions imposed by the Company's revolving credit facility, including financial covenants and limitations on the Company's ability to incur additional indebtedness and the Company's future capital requirements, and other risks, uncertainties and factors set forth under Item 1A., entitled "Risk Factors", in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and in the Company's other reports and documents filed with the SEC.  These forward-looking statements can be identified by the use of words such as "outlook", "believes", "expects", "potential", "continues", "may", "will", "should", "seeks", "predicts", "intends", "plans", "estimates", "anticipates", "target", "could" or the negative version of these words or other comparable words.  These statements are subject to various risks and uncertainties, many of which are outside the Company's control, including, among others the strength of the economy, changes in the overall level of consumer spending, the performance of the Company's products within the prevailing retail environment, trade restrictions, availability of suitable store locations at appropriate terms, the availability of raw material and other specific factors discussed herein and in other Company SEC filings (including reports on Forms 10-K and 10-Q filed with the SEC).  The Company believes that all forward-looking statements are based on reasonable assumptions when made; however,  it is impossible to predict actual results or outcomes or the effects of risks, uncertainties or other factors on anticipated results or outcomes with certainty and that, accordingly, one should not place undue reliance on these statements.  Forward-looking statements speak only as of the date when made and the Company undertakes no obligation to update these statements in light of subsequent events or developments. Actual results may differ materially from anticipated results or outcomes discussed in any forward-looking statement.

TABLE 1

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended

Six Months Ended

July 1,

June 25,

July 1,

June 25,

2017

2016

2017

2016

Net sales

$         304,837

$         332,717

$         621,738

$         669,491

Cost of goods sold

218,222

224,893

436,309

445,420

Gross profit

86,615

107,824

185,429

224,071

Selling, general and administrative expenses

86,779

87,100

169,984

175,867

Goodwill and store fixed-asset impairment charges

168,090

-

168,090

218

Income (loss) from operations

(168,254)

20,724

(152,645)

47,986

Interest expense, net

2,374

2,352

4,786

4,614

Income (loss) before provision (benefit) for income taxes

(170,628)

18,372

(157,431)

43,372

Provision (benefit) for income taxes

(14,209)

7,939

(9,008)

18,157

Net income (loss)

$        (156,419)

$           10,433

$       (148,423)

$           25,215

Weighted average common shares outstanding

   Basic

23,231,453

23,763,934

23,029,849

24,283,135

   Diluted

23,231,453

23,938,978

23,029,849

24,474,018

Net income (loss) per common share

   Basic

$             (6.73)

$              0.44

$            (6.44)

$              1.04

   Diluted

$             (6.73)

$              0.44

$            (6.44)

$              1.03

TABLE 2

VITAMIN SHOPPE, INC. AND SUBSIDIARY

SEGMENT DATA, KEY PERFORMANCE INDICATORS AND STORE INFO

($ in thousands)

(Unaudited)

Three Months Ended

Six Months Ended

July 1,

June 25,

July 1,

June 25,

2017

2016

2017

2016

Net sales:

Retail 

$             296,419

$             321,063

$             602,191

$             644,927

Manufacturing

23,349

20,778

45,014

41,338

Segment net sales

319,768

341,841

647,205

686,265

Elimination of intersegment revenues

(14,931)

(9,124)

(25,467)

(16,774)

Net sales

$             304,837

$             332,717

$             621,738

$             669,491

Income (Loss) from operations:

Retail 

$               24,402

$               37,356

$               58,427

$               82,107

Manufacturing

(15,881)

(1,822)

(19,113)

(2,084)

Corporate costs

(176,775)

(14,810)

(191,959)

(32,037)

Income (Loss) from operations

$            (168,254)

$               20,724

$            (152,645)

$               47,986

Increase (Decrease) in total comparable net sales

(8.3)%

1.6 %

(7.3)%

(0.2)%

Increase (Decrease) in comparable store net sales

(7.6)%

0.8 %

(6.7)%

(0.9)%

Increase (Decrease) in VS.com comparable net sales

(20.2)%

15.2 %

(14.6)%

8.3 %

Gross profit as a percent of net sales

28.4 %

32.4 %

29.8 %

33.5 %

Income (Loss) from operations as a percent of net sales

(55.2)%

6.2 %

(24.6)%

7.2 %

Capital Expenditures

$               18,240

$                 9,324

$               28,378

$               21,005

Depreciation and Amortization 

$                 8,011

$                 9,377

$               15,839

$               19,440

Store Data:

Stores open at beginning of period 

780

766

775

758

    Stores opened 

3

9

9

18

    Stores closed 

(4)

(1)

(5)

Stores open at end of period

783

771

783

771

Total retail square footage at end of period (in thousands)

2,731

2,701

2,731

2,701

TABLE 3

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

July 1,

December 31,

2017

2016

ASSETS

Current assets:

  Cash and cash equivalents

$                  2,003

$                   2,833

  Accounts receivable, net of allowance of $2,356 and $1,061 in 2017 and 2016, respectively

2,958

7,367

  Inventories

233,315

241,736

  Prepaid expenses and other current assets

36,603

33,717

     Total current assets

274,879

285,653

Property and equipment, net of accumulated depreciation and amortization of $327,031 and $305,777
   in 2017 and 2016, respectively

151,509

139,132

Goodwill

46,308

210,633

Other intangibles, net

79,104

79,489

Other long-term assets

30,691

19,277

Total assets

$              582,491

$               734,184

LIABILITIES AND STOCKHOLDERS' EQUITY 

Current liabilities:

  Revolving credit facility

$                  3,000

$                 11,000

  Accounts payable

54,216

65,606

  Accrued expenses and other current liabilities

63,992

57,499

     Total current liabilities

121,208

134,105

Convertible notes, net

123,622

120,874

Deferred rent

39,902

37,489

Other long-term liabilities 

2,240

1,720

Commitments and contingencies

Stockholders' equity:

  Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued

   and outstanding at July 1, 2017 and December 31, 2016

-

-

  Common stock, $0.01 par value; 400,000,000 shares authorized, 24,013,113 shares issued and

     23,821,837 shares outstanding at July 1, 2017, and 23,585,240 shares issued and 23,424,055

     shares outstanding at December 31, 2016

240

236

  Additional paid-in capital

85,213

80,727

  Treasury stock, at cost; 191,276 shares at July 1, 2017 and 161,185 shares at December 31, 2016

(6,974)

(6,430)

  Retained earnings 

217,040

365,463

           Total stockholders' equity 

295,519

439,996

Total liabilities and stockholders' equity

$              582,491

$               734,184

TABLE 4

VITAMIN SHOPPE, INC. AND SUBSIDIARY

SUPPLEMENTAL OPERATING DATA

(Unaudited)

Amounts in millions except per share data

Figures may not sum due to rounding

Gross

Goodwill
and Store
Fixed-Asset
Impairment

Operating 

Net

Diluted

Profit

SG&A

Charges

Income (Loss)

Income (Loss)

EPS

Three months ended July 1, 2017:

As Reported

$         86.6

$         86.8

$              168.1

$            (168.3)

$             (156.4)

$        (6.73)

Goodwill impairment (1)

-

-

(164.3)

164.3

151.3

6.51

Nutri-Force turnaround costs (2)

10.7

(3.0)

-

13.7

8.2

0.36

Store impairment charges (3)

-

-

(3.8)

3.8

2.3

0.10

As Adjusted

$           97.3

$           83.8

$                     -

$                 13.5

$                    5.4

$           0.23

Three months ended June 25, 2016:

As Reported

$       107.8

$         87.1

$                     -

$                20.7

$                 10.4

$         0.44

Canada stores closing costs (4)

-

(1.9)

-

1.9

1.9

0.08

Cost reduction project (5)

-

(1.5)

-

1.5

0.9

0.04

As Adjusted

$         107.8

$           83.7

$                     -

$                 24.1

$                  13.2

$           0.55

Six months ended July 1, 2017:

As Reported

$       185.4

$       170.0

$              168.1

$            (152.6)

$             (148.4)

$        (6.44)

Goodwill impairment (1)

-

-

(164.3)

164.3

151.3

6.57

Nutri-Force turnaround costs (2)

10.7

(3.6)

-

14.3

8.7

0.38

Store impairment charges (3)

-

-

(3.8)

3.8

2.3

0.10

As Adjusted

$         196.1

$         166.4

$                     -

$                 29.8

$                  13.8

$           0.60

Six months ended June 25, 2016:

As Reported

$       224.1

$       175.9

$                  0.2

$                48.0

$                 25.2

$         1.03

Canada stores closing costs (4)

(0.2)

(3.0)

-

2.8

2.8

0.11

Cost reduction project (5)

-

(1.5)

-

1.5

0.9

0.04

Super Supplements conversion costs (6)

(0.2)

(1.3)

-

1.0

0.6

0.03

Reinvention strategy costs (7)

-

(0.5)

-

0.5

0.3

0.01

As Adjusted

$         223.7

$         169.6

$                   0.2

$                 53.9

$                  29.9

$           1.22

(1) Impairment charge on the goodwill of the retail segment.

(2) The costs represent restructuring costs related to the turnaround of Nutri-Force.

(3) Impairment charges on the fixed assets of retail locations still in use in the Company's operations.

(4) Costs primarily include lease termination charges.

(5) Outside consulting costs relating to a project to identify and implement cost reduction opportunities.

(6) Costs primarily related to the closure of the Seattle distribution center.

(7) The costs represent outside consultants fees in connection with the Company's "reinvention strategy".

TABLE 5

VITAMIN SHOPPE, INC. AND SUBSIDIARY

ADJUSTED 2017 GUIDANCE

(Unaudited)

Dollars in millions

Figures may not sum due to rounding

Fiscal Year
Ending
December 30, 2017
(Projected)

Gross Margin Rate - GAAP basis

30.2% to 30.7%

Nutri-Force turnaround costs

0.9%

Closing of North Bergen facility

0.3%

Gross Margin Rate - Adjusted basis

31.3% to 31.8%

SG&A - GAAP basis

$342 to $347 

Nutri-Force turnaround costs

(7)

SG&A - Adjusted basis

$335 to $340 

View original content:http://www.prnewswire.com/news-releases/vitamin-shoppe-inc-announces-second-quarter-2017-results-300501696.html

SOURCE Vitamin Shoppe, Inc.

NEXT ARTICLE

More From BioPortfolio on "Vitamin Shoppe, Inc. Announces Second Quarter 2017 Results"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...